What is the recommended taper schedule for 0.5 mg of Xanax (alprazolam) daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tapering Off 0.5 mg of Xanax (Alprazolam) Daily

For a patient taking 0.5 mg of Xanax daily, the recommended tapering schedule is to reduce the dose by no more than 0.5 mg every 3 days, with a slower reduction of approximately 5-10% of the original dose every 1-2 weeks being more appropriate for most patients. 1, 2

Tapering Schedule for 0.5 mg Alprazolam

Initial Approach

  • For 0.5 mg daily dose, implement a gradual taper:
    • Week 1-2: Reduce to 0.375 mg daily (25% reduction)
    • Week 3-4: Reduce to 0.25 mg daily
    • Week 5-6: Reduce to 0.125 mg daily
    • Week 7-8: Reduce to 0.0625 mg daily (if possible to split the pill)
    • Week 9: Discontinue

Dosing Strategy

  • Divide the daily dose into 3-4 evenly spaced doses throughout the day to minimize interdose withdrawal symptoms 1
  • For example, if taking 0.25 mg daily, consider 0.125 mg twice daily

Managing Withdrawal Symptoms

Common Withdrawal Symptoms

  • Anxiety, irritability, insomnia, tremor, sweating, agitation, hypertension, tachycardia 2
  • More severe symptoms may include seizures or psychosis (rare but serious)

Symptom Management

  • Non-pharmacological approaches:

    • Cognitive behavioral therapy significantly increases tapering success rates 2
    • Regular exercise, sleep hygiene practices, and stress management techniques
  • Pharmacological adjuncts for specific symptoms:

    • Insomnia: Trazodone or hydroxyzine
    • Anxiety: Hydroxyzine or gabapentin
    • Sympathetic hyperactivity: Clonidine
    • Pain: Scheduled acetaminophen (not exceeding 3000mg daily) 2

Special Considerations

Slower Taper May Be Needed

  • If withdrawal symptoms become intolerable, return to the previous dose and stabilize before attempting a slower taper 1
  • Some patients may require an even more gradual taper of 5% reduction every 2-4 weeks 2
  • The FDA drug label specifically notes: "If significant withdrawal symptoms develop, the previous dosing schedule should be reinstituted and, only after stabilization, should a less rapid schedule of discontinuation be attempted" 1

Risk Factors for Difficult Withdrawal

  • Elderly patients require more gradual tapering (5% reduction every 2 weeks) 2
  • Patients with a history of anxiety disorders or seizure disorders need closer monitoring 2
  • High Eysenck neuroticism and female sex have been identified as predictors of more difficult withdrawal 3

Common Pitfalls to Avoid

  • Avoid abrupt discontinuation - This can lead to severe withdrawal symptoms including seizures 1
  • Don't taper too quickly - The FDA label warns against reducing by more than 0.5 mg every 3 days 1
  • Don't mistake withdrawal for recurrence - Withdrawal symptoms can mimic the return of anxiety symptoms
  • Don't underestimate the final stages - The most difficulty is often experienced in the last half of the taper 3

Monitoring During Taper

  • Assess for withdrawal symptoms before each dose reduction
  • If symptoms become significant, slow the taper rate
  • Some patients (up to 32-42%) may be unable to achieve a completely drug-free state and may require maintenance on the lowest effective dose 3

Remember that while the FDA recommends reducing by no more than 0.5 mg every 3 days, this is often too fast for many patients, especially those on long-term therapy. A more gradual approach of 5-10% reduction every 1-2 weeks is generally better tolerated and more successful for most patients.

References

Guideline

Tapering Benzodiazepines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.